Novartis AG
OTC:NVSEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
OTC:NVSEF
|
CH |
|
G
|
Gildan Activewear Inc
XBER:VGA
|
CA |
|
Penske Automotive Group Inc
F:UA9
|
US |
|
Steel Dynamics Inc
NASDAQ:STLD
|
US |
|
Banco Santander SA
F:BSD2
|
ES |
|
P
|
Patterson-UTI Energy Inc
XBER:PE1
|
US |
|
G
|
GoGold Resources Inc
XMUN:GGD
|
CA |
|
M
|
Micron Technology Inc
F:MTE
|
US |
|
Loop Industries Inc
F:3L9
|
CA |
|
Fugro NV
F:F3DC
|
NL |
|
G
|
Geo Group Inc
F:GEG
|
US |
|
T
|
Tapestry Inc
DUS:COY
|
US |
|
O
|
Oracle Corp
XBER:ORC
|
US |
|
S
|
Sirius XM Holdings Inc
F:RDO
|
US |
|
C
|
Compagnie de Saint Gobain SA
F:GOB
|
FR |
|
Itochu Corp
TSE:8001
|
JP |
|
S
|
Sony Group Corp
XBER:SON1
|
JP |
|
T
|
TransDigm Group Inc
XBER:T7D
|
US |
Wall St Price Targets
NVSEF Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NVSEF is 155 USD with a low forecast of 117.83 USD and a high forecast of 185.04 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVSEF's stock price target?
Price Target
155
USD
According to Wall Street analysts, the average 1-year price target for NVSEF is 155 USD with a low forecast of 117.83 USD and a high forecast of 185.04 USD.
What is the Revenue forecast for Novartis AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 12%.
